Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02464904 · ClinicalTrials.gov registry record · NA

Intrapleural Cryotherapy for Malignant Pleural Mesothelioma

A NA study, sponsored by Mayo Clinic.

Terminated
Registry status
NA
Development phase
17
Enrollment target

NCT02464904: Clinical Trial NA study, sponsored by Mayo Clinic.

NCT02464904 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02464904, a NA study, was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

Can neoadjuvant intrapleural cryotherapy be safely performed in patients with malignant pleural mesothelioma and will it trigger substantial systemic and local pro-inflammatory changes, resulting in the induction of anti-tumor immunity?

Primary Outcome

Participants will be monitored for any adverse events that may have resulted from the pleuroscopy procedure.

Interventions

  • OTHER Control
  • PROCEDURE Cryotherapy

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2015-07
Est. Completion 2021-02-26
Phase NA
Mayo Clinic

2,844 total trials

Why NCT02464904 stopped before completion

NCT02464904 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT02464904 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02464904 about?

NCT02464904 is a clinical study titled "Intrapleural Cryotherapy for Malignant Pleural Mesothelioma". Can neoadjuvant intrapleural cryotherapy be safely performed in patients with malignant pleural mesothelioma and will it trigger substantial systemic and local pro-inflammatory changes, resulting in the induction of anti-tumor immunity?

What is the current status of trial NCT02464904?

This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2015-07. Estimated completion is 2021-02-26.

What interventions are being tested in trial NCT02464904?

The interventions under investigation include: Control (OTHER), Cryotherapy (PROCEDURE).

Who is sponsoring clinical trial NCT02464904?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02464904's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02464904, the US trial registry maintained by the National Library of Medicine. NCT02464904 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.